Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Neurimmune

    Client Virtual Booth

    NEURIMMUNE

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Neurimmune
    Switzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Wagistrasse 13 CH-8952 Schlieren-Zurich
    Telephone
    Telephone
    +41 44 755 46 59
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.neurimmune.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/neurimmune
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Neurimmune to regain rights to brain amyloid depleter for Alzheimer™s disease
    Neurimmune to regain rights to brain amyloid depleter for Alzheimer™s disease

    https://www.globenewswire.com/news-release/2024/01/31/2821023/0/en/Neurimmune-to-regain-global-rights-to-brain-amyloid-depleter-for-the-treatment-of-Alzheimer-s-disease.html

    GLOBENEWSWIRE
    31 Jan 2024
    Share Share
    Neurimmune to preset results of phase 1b proof-of-concept study of NI006
    Neurimmune to preset results of phase 1b proof-of-concept study of NI006

    http://www.pharmabiz.com/NewsDetails.aspx?aid=158207&sid=2

    PHARMABIZ
    19 May 2023
    Share Share
    Biogen CEO points to risk in neuroscience as 3 programs cut
    Biogen CEO points to risk in neuroscience as 3 programs cut

    https://www.fiercebiotech.com/biotech/biogen-ceo-michel-vounatsos-points-inherent-risk-neuroscience-3-programs-cut

    Annalee Armstrong FIERCEBIOTECH
    21 Jul 2022
    Share Share
    AstraZeneca, Swiss firm Neurimmune ink $760 million deal for antibody drug
    AstraZeneca, Swiss firm Neurimmune ink $760 million deal for antibody drug

    https://www.reuters.com/world/uk/astrazeneca-inks-760-mln-deal-with-swiss-firm-neurimmune-antibody-drug-2022-03-01/

    Pushkala Aripaka REUTERS
    01 Mar 2022
    Share Share
    Neurimmune expands drug discovery collaboration with Ono Pharmaceutical
    Neurimmune expands drug discovery collaboration with Ono Pharmaceutical

    https://www.prnewswire.com/news-releases/neurimmune-expands-drug-discovery-collaboration-with-ono-pharmaceutical-in-the-field-of-neurodegenerative-diseases-301461904.html

    PRNEWSWIRE
    17 Jan 2022
    Share Share
    FDA Approval of Aducanumab
    FDA Approval of Aducanumab

    https://www.prnewswire.com/news-releases/fda-approval-of-aducanumab-301307169.html

    PRNEWSWIRE
    07 Jun 2021
    Share Share
    Neurimmune Announces the Initiation of a Phase 1 Study of NI006
    Neurimmune Announces the Initiation of a Phase 1 Study of NI006

    https://www.prnewswire.com/news-releases/neurimmune-announces-the-initiation-of-a-phase-1-study-of-ni006-for-the-treatment-of-attr-cardiomyopathy-301011977.html

    PR NEWSWIRE
    27 Feb 2020
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search